ID 205005527 · FY 2017–2023 · 7 years
Subsidiary of შეზღუდული პასუხისმგებლობის საზოგადოება კლინიკური ონკოლოგიის ინსტიტუტი (86.2%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,153 | 5,409 | 4,645 | 4,525 | 5,165 | 4,853 | 4,284 | -3.0% |
| Total COGS | -1,666 | -1,622 | -1,605 | -1,216 | -1,434 | -1,497 | -1,361 | -3.3% |
| Gross Profit | 3,488 | 3,787 | 3,040 | 3,309 | 3,730 | 3,356 | 2,923 | -2.9% |
| Gross Margin | 67.7% | 70.0% | 65.5% | 73.1% | 72.2% | 69.2% | 68.2% | |
| Total Operating Expenses | -2,070 | -3,502 | -2,877 | -2,993 | -3,538 | -3,257 | -2,726 | +4.7% |
| EBITDA | 1,417 | 285 | 163 | 316 | 192 | 99 | 198 | -28.0% |
| EBITDA Margin | 27.5% | 5.3% | 3.5% | 7.0% | 3.7% | 2.0% | 4.6% | |
| Total D&A | 117 | 0 | -110 | -64 | -95 | -87 | -83 | nmf |
| EBIT / Operating Income | 1,534 | 285 | 53 | 252 | 97 | 12 | 115 | -35.1% |
| Total Interest Income | 0 | 160 | 160 | 0 | 0 | 13 | 18 | -35.1% |
| Total Interest Expense | 0 | 0 | -156 | -138 | -155 | -120 | -111 | -8.1% |
| Total Other Income | 0 | 0 | -152 | -292 | -1 | 348 | 222 | nmf |
| Profit Before Tax | 1,534 | 445 | -94 | -179 | -59 | 254 | 244 | -26.4% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 1,417 | 285 | 11 | 23 | 823 | 447 | 301 | -22.7% |
| Net Margin | 27.5% | 5.3% | 0.2% | 0.5% | 15.9% | 9.2% | 7.0% |
Ownership & directors from companyinfo.ge (public corporate registry).